Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind randomized placebo-controlled trial of Trichuris suis ova in active Crohn's disease
2006-000720-13Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Jan 2010
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of trichuris suis ova in Crohn's disease (4 arms), sponsored by Dr. Falk Pharma GmbH. Primary endpoint: Clinical remission at week 12. Started Jan 2010; status: completed.
02
Drugs
trichuris suis ova
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2006-000720-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000720-13.